Current status of immunologic approaches to treating tobacco dependence: vaccines and nicotine-specific antibodies.
about
Nicotinic Receptors: Role in Addiction and Other Disorders of the Brain.New directions in nicotine vaccine design and use.A molecular model for cocaine binding by the immunotherapeutic human/mouse chimeric monoclonal antibody 2E2.Combined cocaine hydrolase gene transfer and anti-cocaine vaccine synergistically block cocaine-induced locomotion.High immunogenicity of nicotine vaccines obtained by intradermal delivery with safe adjuvants.Scientific overview: 2013 BBC plenary symposium on tobacco addiction.Neuroscience of behavioral and pharmacological treatments for addictionsCombined active and passive immunization against nicotine: minimizing monoclonal antibody requirements using a target antibody concentration strategyEffects of active anti-methamphetamine vaccination on intravenous self-administration in rats.Enhanced attenuation of nicotine discrimination in rats by combining nicotine-specific antibodies with a nicotinic receptor antagonistA methamphetamine vaccine attenuates methamphetamine-induced disruptions in thermoregulation and activity in ratsCurrent and emerging pharmacotherapies for treating tobacco dependence.Vaccines in the Treatment of Substance AbuseAAV-directed persistent expression of a gene encoding anti-nicotine antibody for smoking cessationSuppression of nicotine-induced pathophysiology by an adenovirus hexon-based antinicotine vaccine.Substance abuse vaccines.Nicotine vaccines to assist with smoking cessation: current status of research.Mechanism-based medication development for the treatment of nicotine dependence.Prospects, promise and problems on the road to effective vaccines and related therapies for substance abuseEffects of the nicotinic receptor partial agonists varenicline and cytisine on the discriminative stimulus effects of nicotine in rats.Passive immunization with a nicotine-specific monoclonal antibody decreases brain nicotine levels but does not precipitate withdrawal in nicotine-dependent rats.Immunopharmacotherapy: vaccination strategies as a treatment for drug abuse and dependence.Anti-drug vaccines to treat substance abuse.Nicotine vaccines to treat tobacco dependence.The next-generation nicotine vaccine: a novel and potent hybrid nanoparticle-based nicotine vaccine.A nanoparticle-based nicotine vaccine and the influence of particle size on its immunogenicity and efficacy.
P2860
Q33635666-056DFF4A-A658-40C3-BFAD-2F14E42584F8Q33719424-E044054F-F6B5-4F8E-A2BA-C885E9504C0AQ33801980-E6F50711-7566-42CE-A014-FFA939D22A15Q34389675-CEDAA686-17DE-410B-B3CB-D236655FF78EQ34466125-68882F06-6F2E-4F21-9B3A-A2FBFC818185Q34487271-466B9858-F713-4B90-AECC-2FB0FBDC0BFBQ34714494-9312BBBA-78BC-4BDE-B7E7-112CD3716821Q35476326-AB6DD503-7920-41B1-8C03-92365FB07E74Q35875875-1405719D-C131-4FE7-BA50-EE8507B56761Q35975765-60A08C1E-923D-438E-AC4C-ED2253D8A4C9Q36579253-BCF7C01E-0093-400C-8F5C-630617EE5B2FQ36580581-47B3772C-127E-46D8-8E00-1695BB9ECC9CQ36655861-FF5BBAAA-2679-4B52-BB10-8555C5CAEDAFQ36756701-1EDCB0D4-D74D-4D43-B0FA-6150A1EA281CQ36945794-8AD60674-8D82-492D-9532-BB5EF9AE0FB9Q36983386-0425F6F9-A2D4-4151-AE70-0E850952E343Q36987118-9563028D-0816-467C-B505-924BCC64FA41Q37018610-4CDA1C3B-F142-4FAD-9753-6604F5837B9EQ37082158-36591810-AA63-4A50-A0E0-4B77F8D5AFE9Q37121061-911A53A0-6D2F-4552-9C71-89F2074CB1EDQ37260093-D75183D9-10C6-4A72-A746-FD6F2C7E7D5CQ37401384-9A3CA97D-DEE7-4A76-80B2-61084EE48081Q37427396-AD83EFCA-5EAA-463A-9D5A-E9F1255857A0Q38056382-4F55E2ED-39C3-481A-B409-A4FA6681EDF5Q42627924-33AE1416-B5B7-4E07-9050-479CA0913025Q45040238-127AFC9F-212A-48BA-91E3-1A49C18FB874
P2860
Current status of immunologic approaches to treating tobacco dependence: vaccines and nicotine-specific antibodies.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Current status of immunologic ...... nicotine-specific antibodies.
@ast
Current status of immunologic ...... nicotine-specific antibodies.
@en
type
label
Current status of immunologic ...... nicotine-specific antibodies.
@ast
Current status of immunologic ...... nicotine-specific antibodies.
@en
prefLabel
Current status of immunologic ...... nicotine-specific antibodies.
@ast
Current status of immunologic ...... nicotine-specific antibodies.
@en
P2093
P2860
P356
P1433
P1476
Current status of immunologic ...... nicotine-specific antibodies.
@en
P2093
Daniel E Keyler
Mark G LeSage
Paul R Pentel
P2860
P2888
P304
P356
10.1208/AAPSJ080108
P407
P577
2006-02-24T00:00:00Z
P5875
P6179
1011266027